This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Avinder Sran: Innovator in JAK Pathway Inhibition
Introduction
Avinder Sran is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target the JAK pathway. His work is crucial for advancing therapeutic methods for various medical conditions.
Latest Patents
Avinder Sran holds a patent for "Compositions and methods for inhibition of the JAK pathway." This invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions where modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful. He has 1 patent to his name.
Career Highlights
Avinder Sran is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to innovate in the field of drug development. His expertise in the JAK pathway has positioned him as a key player in the biotechnology sector.
Collaborations
He has collaborated with notable colleagues such as Vadim Markovtsov and Jeffrey Clough, contributing to a dynamic research environment that fosters innovation.
Conclusion
Avinder Sran's work in the inhibition of the JAK pathway represents a significant advancement in therapeutic strategies. His contributions to biotechnology continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile